BACKGROUND: There is a growing interest in assessing the impact of a disease and the effect of a treatment on a patient's life, expressed as health-related quality of life (HRQoL). HRQoL assessment can provide essential outcome information for cancer surgery. METHODS: The core of this review is derived from a literature search of the Medline database. RESULTS: Three types of HRQoL instrument can be distinguished: generic, disease specific and symptom specific. There are criteria against which HRQoL instruments may be evaluated. The instrument chosen must be reliable, valid and sensitive to change. CONCLUSION: HRQoL measurement may be useful in identifying the optimal surgical procedure. It may also be of help in deciding whether surgery in patients with limited life expectancy should still be considered. No HRQoL instrument fits all the recommended conditions or is suitable in all clinical situations. Using the appropriate instrument is essential to arrive at valid and clinically meaningful outcome measures.
BACKGROUND: There is a growing interest in assessing the impact of a disease and the effect of a treatment on a patient's life, expressed as health-related quality of life (HRQoL). HRQoL assessment can provide essential outcome information for cancer surgery. METHODS: The core of this review is derived from a literature search of the Medline database. RESULTS: Three types of HRQoL instrument can be distinguished: generic, disease specific and symptom specific. There are criteria against which HRQoL instruments may be evaluated. The instrument chosen must be reliable, valid and sensitive to change. CONCLUSION: HRQoL measurement may be useful in identifying the optimal surgical procedure. It may also be of help in deciding whether surgery in patients with limited life expectancy should still be considered. No HRQoL instrument fits all the recommended conditions or is suitable in all clinical situations. Using the appropriate instrument is essential to arrive at valid and clinically meaningful outcome measures.
Authors: A G E M de Boer; J J B van Lanschot; P F M Stalmeier; J W van Sandick; J B F Hulscher; J C J M de Haes; M A G Sprangers Journal: Qual Life Res Date: 2004-03 Impact factor: 4.147
Authors: Hao Wang; Dexiang Zhu; Li Liang; Lechi Ye; Qi Lin; Yunshi Zhong; Ye Wei; Li Ren; Jianmin Xu; Xinyu Qin Journal: Qual Life Res Date: 2015-05-24 Impact factor: 4.147
Authors: Richard J Swartz; George P Baum; Robert L Askew; Judy Lynn Palmer; Merrick I Ross; Janice N Cormier Journal: Melanoma Res Date: 2012-04 Impact factor: 3.599
Authors: Salvatore Pucciarelli; Paola Del Bianco; Fabio Efficace; Paola Toppan; Samantha Serpentini; Maria Luisa Friso; Sara Lonardi; Gian Luca De Salvo; Donato Nitti Journal: Support Care Cancer Date: 2009-07-23 Impact factor: 3.603
Authors: Paula Curitiba Maciel; Joel Veiga-Filho; Marcelo Prado Carvalho; Fernando Elias Martins Fonseca; Lydia Masako Ferreira; Daniela Francescato Veiga Journal: An Bras Dermatol Date: 2014 Jul-Aug Impact factor: 1.896